Reference SummaryMcAnulty PA, Toxicol Pathol 2005;33(5):609-20
Title |
Diethylstilbestrol (DES): carcinogenic potential in Xpa-/-, Xpa-/- / p53+/-, and wild-type mice during 9 months' dietary exposure. | ||||||||
Authors |
McAnulty PA; Skydsgaard M | ||||||||
Journal |
Toxicol Pathol | ||||||||
Volume |
33 | ||||||||
Issue |
5 | ||||||||
Year |
2005 | ||||||||
Pages |
609-20 | ||||||||
Abstract |
DES carcinogenicity has been investigated in 2 mouse knockout models, the Xpa homozygous knockout, and the combined Xpa homozygous and p53 heterozygous knockout. Wild-type (WT) mice were also included. Xpa mice received diets containing DES at concentrations of 0, 100, 300, and 1500 ppb for 39 weeks; Xpa/p53 and WT mice received diets containing 0 or 1500 ppb. There were 15 of each sex per group. Both Xpa and WT mice had a similar incidence of tumors at the high dosage of 1500 ppb, including pituitary adenomas in 4 WT mice and 7 Xpa mice, and single incidences of osteosarcoma (Xpa), T-cell lymphoma (WT and Xpa), and testicular interstitial cell adenoma (WT and Xpa). The incidence of tumors was higher in the Xpa/p53 mice at 1500 ppb, mainly attributable to 5 osteosarcomas in males and 2 in females, but also 4 pituitary adenomas, testicular interstitial cell adenomas in 4 males, and single incidences of cerebral glioma, phaeochromocytoma, and cervical fibrosarcoma. The incidence of osteosarcomas was related to the severity of fibro-osseous lesions in the bone marrow. It was concluded that for carcinogenicity screening, Xpa mice were no more sensitive than wild-type mice for compounds like DES, but the Xpa/p53 model showed an increased sensitivity. | ||||||||
Links |
J:101774 – MGI References 16178126 – National Library of Medicine/PubMed |
||||||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
B6.129P2-Xpatm1Hvs | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0 |
||
B6.129P2-Xpatm1Hvs | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
0 |
|
C57BL/6JIco | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0 |
||
C57BL/6JIco | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
0 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Adrenal gland - Medulla pheochromocytoma |
|
Adrenal gland - Medulla |
0 - 6.7 |
|
B6.129P2-Xpatm1Hvs | Adrenal gland - Subcapsular cell hyperplasia | Adrenal gland - Subcapsular cell |
6.7 - 100 |
||
B6.129P2-Xpatm1Hvs | Adrenal gland - Subcapsular cell hyperplasia |
|
Adrenal gland - Subcapsular cell |
60 - 100 |
|
C57BL/6JIco | Adrenal gland - Subcapsular cell hyperplasia | Adrenal gland - Subcapsular cell |
0 - 100 |
||
C57BL/6JIco | Adrenal gland - Subcapsular cell hyperplasia |
|
Adrenal gland - Subcapsular cell |
87 - 100 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Adrenal gland - Subcapsular cell hyperplasia | Adrenal gland - Subcapsular cell |
33 - 100 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Adrenal gland - Subcapsular cell hyperplasia |
|
Adrenal gland - Subcapsular cell |
93 |
|
B6.129P2-Xpatm1Hvs | Bone lesion | Bone - Sternum |
0 - 6.7 |
||
B6.129P2-Xpatm1Hvs | Bone lesion | Bone - Femur |
0 |
||
B6.129P2-Xpatm1Hvs | Bone lesion |
|
Bone - Sternum |
0 - 60 |
|
B6.129P2-Xpatm1Hvs | Bone lesion |
|
Bone - Femur |
0 - 100 |
|
C57BL/6JIco | Bone lesion | Bone - Sternum |
0 |
||
C57BL/6JIco | Bone lesion | Bone - Femur |
0 - 13 |
||
C57BL/6JIco | Bone lesion |
|
Bone - Sternum |
13 - 27 |
|
C57BL/6JIco | Bone lesion |
|
Bone - Femur |
87 - 100 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Bone lesion | Bone - Sternum |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Bone lesion | Bone - Femur |
0 - 6.7 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Bone lesion |
|
Bone - Sternum |
53 - 60 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Bone lesion |
|
Bone - Femur |
80 |
|
B6.129P2-Xpatm1Hvs | Bone osteosarcoma | Bone |
0 |
||
B6.129P2-Xpatm1Hvs | Bone osteosarcoma |
|
Bone |
0 |
|
B6.129P2-Xpatm1Hvs | Bone osteosarcoma |
|
Bone - Sternum |
6.7 |
|
C57BL/6JIco | Bone osteosarcoma | Bone |
0 |
||
C57BL/6JIco | Bone osteosarcoma |
|
Bone |
0 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Bone osteosarcoma | Bone |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Bone osteosarcoma |
|
Bone |
13 - 33 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Bone osteosarcoma |
|
Leg |
27 |
|
B6.129P2-Xpatm1Hvs | CNS - Brain - Cerebrum glioma | CNS - Brain - Cerebrum |
0 |
||
B6.129P2-Xpatm1Hvs | CNS - Brain - Cerebrum glioma |
|
CNS - Brain - Cerebrum |
0 |
|
C57BL/6JIco | CNS - Brain - Cerebrum glioma | CNS - Brain - Cerebrum |
0 |
||
C57BL/6JIco | CNS - Brain - Cerebrum glioma |
|
CNS - Brain - Cerebrum |
0 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | CNS - Brain - Cerebrum glioma | CNS - Brain - Cerebrum |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | CNS - Brain - Cerebrum glioma |
|
CNS - Brain - Cerebrum |
0 - 6.7 |
|
B6.129P2-Xpatm1Hvs | Connective tissue - Fibroblast fibrosarcoma | Uterus - Cervix |
0 |
||
B6.129P2-Xpatm1Hvs | Connective tissue - Fibroblast fibrosarcoma |
|
Uterus - Cervix |
0 |
|
C57BL/6JIco | Connective tissue - Fibroblast fibrosarcoma | Uterus - Cervix |
0 |
||
C57BL/6JIco | Connective tissue - Fibroblast fibrosarcoma |
|
Uterus - Cervix |
0 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Connective tissue - Fibroblast fibrosarcoma | Uterus - Cervix |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Connective tissue - Fibroblast fibrosarcoma |
|
Uterus - Cervix |
6.7 |
|
B6.129P2-Xpatm1Hvs | Forestomach papilloma |
|
Forestomach |
13 |
|
B6.129P2-Xpatm1Hvs | Forestomach squamous cell carcinoma |
|
Forestomach |
6.7 |
|
B6.129P2-Xpatm1Hvs | Intestine - Large Intestine - Cecum adenoma |
|
Intestine - Large Intestine - Cecum |
6.7 |
|
B6.129P2-Xpatm1Hvs | Intestine - Small Intestine - Duodenum adenocarcinoma |
|
Intestine - Small Intestine - Duodenum |
6.7 |
|
B6.129P2-Xpatm1Hvs | Intestine - Small Intestine - Duodenum adenoma |
|
Intestine - Small Intestine - Duodenum |
6.7 |
|
B6.129P2-Xpatm1Hvs | Intestine - Small Intestine - Ileum adenocarcinoma |
|
Intestine - Small Intestine - Ileum |
6.7 |
|
B6.129P2-Xpatm1Hvs | Intestine - Small Intestine - Ileum adenoma |
|
Intestine - Small Intestine - Ileum |
6.7 |
|
B6.129P2-Xpatm1Hvs | Intestine - Small Intestine - Jejunum adenocarcinoma |
|
Intestine - Small Intestine - Jejunum |
20 |
|
B6.129P2-Xpatm1Hvs | Intestine - Small Intestine - Jejunum adenoma |
|
Intestine - Small Intestine - Jejunum |
20 |
|
B6.129P2-Xpatm1Hvs | Leukocyte - Lymphocyte - B-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - B-lymphocyte |
13 - 20 |
|
B6.129P2-Xpatm1Hvs | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte |
0 |
||
B6.129P2-Xpatm1Hvs | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
0 - 6.7 |
|
B6.129P2-Xpatm1Hvs | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
6.7 |
|
C57BL/6JIco | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte |
0 |
||
C57BL/6JIco | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
0 - 6.7 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Leukocyte - Lymphocyte - T-lymphocyte lymphoma |
|
Leukocyte - Lymphocyte - T-lymphocyte |
0 - 13 |
|
B6.129P2-Xpatm1Hvs | Mammary gland adenocarcinoma | Mammary gland |
0 |
||
B6.129P2-Xpatm1Hvs | Mammary gland adenocarcinoma |
|
Mammary gland |
0 |
|
C57BL/6JIco | Mammary gland adenocarcinoma | Mammary gland |
0 |
||
C57BL/6JIco | Mammary gland adenocarcinoma |
|
Mammary gland |
0 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Mammary gland adenocarcinoma | Mammary gland |
6.7 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Mammary gland adenocarcinoma |
|
Mammary gland |
0 |
|
B6.129P2-Xpatm1Hvs | Mammary gland hyperplasia - focal | Mammary gland |
0 |
||
B6.129P2-Xpatm1Hvs | Mammary gland hyperplasia - focal |
|
Mammary gland |
0 - 73 |
|
C57BL/6JIco | Mammary gland hyperplasia - focal | Mammary gland |
0 |
||
C57BL/6JIco | Mammary gland hyperplasia - focal |
|
Mammary gland |
67 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Mammary gland hyperplasia - focal | Mammary gland |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Mammary gland hyperplasia - focal |
|
Mammary gland |
67 |
|
B6.129P2-Xpatm1Hvs | Pituitary gland - Pars distalis hyperplasia | Pituitary gland - Pars distalis |
0 |
||
B6.129P2-Xpatm1Hvs | Pituitary gland - Pars distalis hyperplasia |
|
Pituitary gland - Pars distalis |
0 - 87 |
|
C57BL/6JIco | Pituitary gland - Pars distalis hyperplasia | Pituitary gland - Pars distalis |
0 |
||
C57BL/6JIco | Pituitary gland - Pars distalis hyperplasia |
|
Pituitary gland - Pars distalis |
80 - 87 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Pituitary gland - Pars distalis hyperplasia | Pituitary gland - Pars distalis |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Pituitary gland - Pars distalis hyperplasia |
|
Pituitary gland - Pars distalis |
73 |
|
B6.129P2-Xpatm1Hvs | Pituitary gland - Pars intermedia hyperplasia | Pituitary gland - Pars intermedia |
0 |
||
B6.129P2-Xpatm1Hvs | Pituitary gland - Pars intermedia hyperplasia |
|
Pituitary gland - Pars intermedia |
0 - 53 |
|
C57BL/6JIco | Pituitary gland - Pars intermedia hyperplasia | Pituitary gland - Pars intermedia |
0 |
||
C57BL/6JIco | Pituitary gland - Pars intermedia hyperplasia |
|
Pituitary gland - Pars intermedia |
47 - 67 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Pituitary gland - Pars intermedia hyperplasia | Pituitary gland - Pars intermedia |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Pituitary gland - Pars intermedia hyperplasia |
|
Pituitary gland - Pars intermedia |
33 - 47 |
|
B6.129P2-Xpatm1Hvs | Pituitary gland adenoma | Pituitary gland |
0 |
||
B6.129P2-Xpatm1Hvs | Pituitary gland adenoma |
|
Pituitary gland |
0 - 33 |
|
C57BL/6JIco | Pituitary gland adenoma | Pituitary gland |
0 |
||
C57BL/6JIco | Pituitary gland adenoma |
|
Pituitary gland |
13 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Pituitary gland adenoma | Pituitary gland |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Pituitary gland adenoma |
|
Pituitary gland |
13 |
|
B6.129P2-Xpatm1Hvs | Prostate gland - Anterior lobe metaplasia - squamous | Prostate gland - Anterior lobe |
0 |
||
B6.129P2-Xpatm1Hvs | Prostate gland - Anterior lobe metaplasia - squamous |
|
Prostate gland - Anterior lobe |
0 - 60 |
|
C57BL/6JIco | Prostate gland - Anterior lobe metaplasia - squamous | Prostate gland - Anterior lobe |
0 |
||
C57BL/6JIco | Prostate gland - Anterior lobe metaplasia - squamous |
|
Prostate gland - Anterior lobe |
87 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Prostate gland - Anterior lobe metaplasia - squamous | Prostate gland - Anterior lobe |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Prostate gland - Anterior lobe metaplasia - squamous |
|
Prostate gland - Anterior lobe |
40 |
|
B6.129P2-Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) |
0 |
||
B6.129P2-Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) adenoma |
|
Testis - Leydig cell (Interstitial cell) |
0 - 20 |
|
C57BL/6JIco | Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) |
0 |
||
C57BL/6JIco | Testis - Leydig cell (Interstitial cell) adenoma |
|
Testis - Leydig cell (Interstitial cell) |
6.7 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) adenoma | Testis - Leydig cell (Interstitial cell) |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) adenoma |
|
Testis - Leydig cell (Interstitial cell) |
27 |
|
B6.129P2-Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
0 |
||
B6.129P2-Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) hyperplasia |
|
Testis - Leydig cell (Interstitial cell) |
0 - 67 |
|
C57BL/6JIco | Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
0 |
||
C57BL/6JIco | Testis - Leydig cell (Interstitial cell) hyperplasia |
|
Testis - Leydig cell (Interstitial cell) |
53 |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) hyperplasia | Testis - Leydig cell (Interstitial cell) |
0 |
||
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Testis - Leydig cell (Interstitial cell) hyperplasia |
|
Testis - Leydig cell (Interstitial cell) |
60 |
|
B6.129P2-Xpatm1Hvs | Uterus - Uterine gland hyperplasia |
|
Uterus - Uterine gland |
observed |
|
C57BL/6JIco | Uterus - Uterine gland hyperplasia |
|
Uterus - Uterine gland |
observed |
|
B6.129-Trp53tm1Tyj/+ Xpatm1Hvs | Uterus - Uterine gland hyperplasia |
|
Uterus - Uterine gland |
observed |